Jose Manuel Larrosa

Jose Manuel Larrosa

Auto-generated profile, based on publicly available information

Jose Manuel Larrosa

Ophthalmology Department, Miguel Servet University Hospital, 50009 Zaragoza, Spain

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Ophthalmology
Verified
Journal Article
Closed access
TSThomas W. Samuelson
Thomas W. Samuelson
DCDavid F. Chang
David F. Chang
RMRobert Marquis
Robert Marquis
BFBrian Flowers
Brian Flowers
KLK. Sheng Lim
K. Sheng Lim
NPNorbert Pfeiffer
Norbert Pfeiffer

1 July 2015 in Ophthalmology
Verified
Journal Article
Closed access
NPNorbert Pfeiffer
Norbert Pfeiffer
JGJulián García-Feijóo
Julián García-Feijóo
Jose M Martinez de la CasaJose M Martinez de la Casa
Jose M Martinez de la Casa
JLJose M. Larrosa
Jose M. Larrosa
AFAntonio Fea
Antonio Fea
TSThomas W. Samuelson
Thomas W. Samuelson

1 February 2014 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
EMELENA GARCIA MARTIN
ELENA GARCIA MARTIN
JLJose M. Larrosa
Jose M. Larrosa
VPVicente Polo
Vicente Polo
MSMaría Satué
María Satué
MMMarcia L. Marques
Marcia L. Marques
LPLuis E. Pablo
Luis E. Pablo

19 February 2016 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
EMELENA GARCIA MARTIN
ELENA GARCIA MARTIN
MBMaria P. Bambo
Maria P. Bambo
MMMarcia L. Marques
Marcia L. Marques
MSMaría Satué
María Satué
SOSofia Otin
Sofia Otin
LPLuis E. Pablo
Luis E. Pablo

1 February 2014 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
EMELENA GARCIA MARTIN
ELENA GARCIA MARTIN
DRDiego Rodriguez-Mena
Diego Rodriguez-Mena
MSMaría Satué
María Satué
CACarmen Almarcegui
Carmen Almarcegui
IDIsabel Dolz
Isabel Dolz
LPLuis E. Pablo
Luis E. Pablo
Purpose. To evaluate correlations between visual evoked potentials (VEP), pattern electroretinogram (PERG), and macular and retinal nerve fiber layer (RNFL) thickness measured by optical coherence tomography (OCT) and the severity of Parkinson disease (PD). Methods. Forty-six PD patients and 33 age and sex-matched healthy controls were enrolled, and underwent VEP, PERG, and OCT measurements of macular and RNFL thicknesses, and evaluation of PD severity using the Hoehn and Yahr scale to measure PD symptom progression, the Schwab and England Activities of Daily Living Scale (SE-ADL) to evaluate patient quality of life (QOL), and disease duration. Logistical regression was performed to analyze which measures, if any, could predict PD symptom progression or effect on QOL. Results. Visual functional parameters (best corrected visual acuity, mean deviation of visual field, PERG positive (P) component at 50 ms -P50- and negative (N) component at 95 ms -N95- component amplitude, and PERG P50 component latency) and structural parameters (OCT measurements of RNFL and retinal thickness) were decreased in PD patients compared with healthy controls. OCT measurements were significantly negatively correlated with the Hoehn and Yahr scale, and significantly positively correlated with the SE-ADL scale. Based on logistical regression analysis, fovea thickness provided by OCT equipment predicted PD severity, and QOL and amplitude of the PERG N95 component predicted a lower SE-ADL score. Conclusions. Patients with greater damage in the RNFL tend to have lower QOL and more severe PD symptoms. Foveal thicknesses and the PERG N95 component provide good biomarkers for predicting QOL and disease severity.

20 October 2016 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
MSMaría Satué
María Satué
JOJavier Obis
Javier Obis
MSMARIA JESUS RODRIGO SANJUAN
MARIA JESUS RODRIGO SANJUAN
SOSofia Otin
Sofia Otin
MFMaria I. Fuertes
Maria I. Fuertes
EMELENA GARCIA MARTIN
ELENA GARCIA MARTIN
Neurodegenerative diseases present a current challenge for accurate diagnosis and for providing precise prognostic information. Developing imaging biomarkers for multiple sclerosis (MS), Parkinson disease (PD), and Alzheimer’s disease (AD) will improve the clinical management of these patients and may be useful for monitoring treatment effectiveness. Recent research using optical coherence tomography (OCT) has demonstrated that parameters provided by this technology may be used as potential biomarkers for MS, PD, and AD. Retinal thinning has been observed in these patients and new segmentation software for the analysis of the different retinal layers may provide accurate information on disease progression and prognosis. In this review we analyze the application of retinal evaluation using OCT technology to provide better understanding of the possible role of the retinal layers thickness as biomarker for the detection of these neurodegenerative pathologies. Current OCT analysis of the retinal nerve fiber layer and, specially, the ganglion cell layer thickness may be considered as a good biomarker for disease diagnosis, severity, and progression.